hydrochlorothiazide has been researched along with oxybutynin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Aggarwal, A; Agrawal, SS | 1 |
| Marcinkowska, J; Posadzy-Malaczynska, A; Rajpold, K; Woznicka-Leskiewicz, L | 1 |
1 review(s) available for hydrochlorothiazide and oxybutynin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for hydrochlorothiazide and oxybutynin
| Article | Year |
|---|---|
Randomised, cross-over, comparative bioavailability trial of matrix type transdermal drug delivery system (TDDS) of carvedilol and hydrochlorothiazide combination in healthy human volunteers: a pilot study.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Antihypertensive Agents; Area Under Curve; Biological Availability; Carbazoles; Carvedilol; Cross-Over Studies; Drug Combinations; Drug Eruptions; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Pilot Projects; Propanolamines; Transdermal Patch; Young Adult | 2010 |
Hemodynamic and metabolic effects of estrogen plus progestin therapy in hypertensive postmenopausal women treated with an ACE-inhibitor or a diuretic.
Topics: Administration, Cutaneous; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Diuretics; Drug Combinations; Drug Interactions; Estradiol; Estrogen Replacement Therapy; Female; Humans; Hydrochlorothiazide; Hypertension; Iodine Radioisotopes; Iodohippuric Acid; Norethindrone; Perindopril; Poland; Polypharmacy; Postmenopause; Progestins; Pulse Wave Analysis; Renal Plasma Flow; Time Factors; Transdermal Patch; Treatment Outcome; Vascular Stiffness | 2015 |
2 other study(ies) available for hydrochlorothiazide and oxybutynin
| Article | Year |
|---|---|
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |